NovaBay Pharmaceuticals, Inc. (NBY)
US — Healthcare Sector
Automate Your Wheel Strategy on NBY
With Tiblio's Option Bot, you can configure your own wheel strategy including NBY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NBY
- Rev/Share 1.347
- Book/Share 1.1618
- PB 0.4768
- Debt/Equity 0.1824
- CurrentRatio 2.9469
- ROIC -0.9683
- MktCap 3222175.0
- FreeCF/Share -0.9269
- PFCF -0.6549
- PE 0.8032
- Debt/Assets 0.114
- DivYield 0
- ROE 2.2554
- Rating A+
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About NovaBay Pharmaceuticals, Inc. (NBY)
- IPO Date 2007-10-26
- Website https://novabay.com
- Industry Biotechnology
- CEO Mr. Justin M. Hall Esq., J.D.
- Employees 13
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.